Answers are grounded in this paper and cite their sources.
This Viewpoint discusses recent legal directives by the DHHS and FDA that could increase health care entities’ liability for possible discriminatory biases of clinical algorithms and the need for additional legal clarity to avoid adverse effects on algorithm development and use.
No takes yet. Share an insight, caveat, or question.
Goodman et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: